CMS certification 414000
Butler Hospital
345 Blackstone Blvd, Providence, RI 02906
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
Clinicians registered at this address
301 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Psychiatry | 148 |
| Clinical | 41 |
| Psychologist | 16 |
| Psychiatric/Mental Health | 14 |
| Physician Assistant | 12 |
| Mental Health | 9 |
| Clinical Neuropsychologist | 8 |
| Pharmacist | 6 |
| Child & Adolescent Psychiatry | 4 |
| Family | 4 |
| Geriatric Psychiatry | 4 |
| Internal Medicine | 4 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $3.9M
- 2020 $3.6M
- 2021 $4.2M
- 2022 $1.3M
- 2023 $2.7M
- 2024 $971,611
- 2025 $1.9M
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Eisai Inc. | $972,275 | 48 |
| Eli Lilly and Company | $441,291 | 6 |
| Janssen Research & Development, LLC | $275,091 | 22 |
| E.R. Squibb & Sons, L.L.C. | $112,549 | 2 |
| Biogen, Inc. | $39,198 | 2 |
| Neuronetics, Inc. | $10,000 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With… Eisai Inc. | $711,298 |
| LONG-TERM REAL-WORLD COMPARATIVE EFFECTIVENESS OF DONANEMAB PLUS USUAL CARE VERSUS USUAL CARE ALONE IN US PATIENTS WITH EARLY SYMPTOMATIC ALZHEIMER'S… Eli Lilly and Company · NCT06566170 | $364,027 |
| A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Su… Eisai Inc. | $260,978 |
| A Randomized Double blind Placebo controlled Parallel group Multi Center Study to Assess the Efficacy and Safety of JNJ63733657 an Antitau Monoclonal… Janssen Research & Development, LLC | $151,752 |
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a P… Janssen Research & Development, LLC | $123,339 |
| A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoc… E.R. Squibb & Sons, L.L.C. | $112,549 |
| A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE Eli Lilly and Company · NCT06653153 | $38,898 |
| A STUDY OF DIFFERENT DONANEMAB (LY3002813) DOSING REGIMENS IN ADULTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 6) Eli Lilly and Company · NCT05738486 | $38,367 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
Common questions about Butler Hospital
Does Butler Hospital have an emergency room?
No. CMS does not list emergency services at Butler Hospital.
Does Butler Hospital receive money from drug and device companies?
Drug and device makers reported $1.9M in payments to Butler Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.